Search results for

Victims of trade secrets misappropriation often seek monetary awards to compensate for their loss. John P Fry and Robert L Lee analyze how US courts have calculated damages in recent trade secrets cases

Genaro Hathaway, assistant general counsel, The Timberland Company

Copyright and contractual issues pose serious challenges to internet companies and their suppliers. David Sternbach of A&E Television Networks Interactive identifies three problems that recur, and suggests practical solutions to them

Indonesia has made slow progress in tackling the piracy that has thwarted IP rights owners in the country. Nicholas Redfearn examines the country’s attempts to develop effective protection and reveals how some rights owners are coping with the problems

The month in figures

Tegal Corp v Tokyo Electron Co, 58 USPQ2d 1791 (Fed Cir, May 14 2001) involves the interesting issue of what constitutes conduct contemptuous of an injunction against wilful patent infringement under US law.

As many technology-rich companies face economic problems, they are looking to their intellectual property to raise money. Zack Clement, Johnathan Bolton and Carmen R Eggleston analyze the role of IP rights and licences in financial restructuring

When, in 1993, Czechoslovakia separated into two independent states, the Czech Republic and Slovakia, both republics incorporated Czechoslovak valid law into their legislation. As far as IP rights are concerned, the most important act was the Patents Act No 527/90. In the following years both republics were working on their own legislation and individual Trade Marks Acts were adopted. However, the work continued. International cooperation required substantial harmonization with legislation of the European Union and as far as patent law was concerned; the work was focused on substantial harmonisation with EPC.

Australia: MicroMedical Industries has been granted a second US patent for technology relating to a blood pump used in its artificial hearts. The patent brings the company one step closer to conducting human clinical trials of the artificial heart.

Flairis Technology (Flairis), a local contract manufacturer, has obtained a court injunction to stop four of its ex-staff from using the company's trade secrets after quitting to join a competitor.